v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities:    
Net loss $ (12,290) $ (34,721)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 1,545 885
Amortization of debt discount 402 859
Change in fair value of derivatives (9,416) (2,004)
Change in fair value of share payable (265) 263
Change in fair value of convertible notes (11,667) (6,089)
Loss from extinguishment of debt 6,936 11,798
Loss from issuance of debt 738 773
Inducement expense 87  
Non - cash financing cost 150  
Amortization of operating lease right-of-use asset 154 130
Stock-based compensation for services 469 749
Allowance for credit loss 325  
Subtotal of non-cash charges (10,542) 7,364
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 154 111
Other non-current assets 2 3
Accounts payable and accrued expenses 3,608 7,534
Related party accounts payable and accrued expenses (364) 3,564
Lease liabilities (246) 39
Net cash used in operating activities (19,678) (16,106)
Cash Flows from Investing Activities:    
Purchase of equipment and construction in progress (327) (397)
Net cash used in investing activities (327) (397)
Cash Flows from Financing Activities:    
Proceeds from issuance of common shares 3,004 12,442
Proceeds from exercise of warrants 20 23
Proceeds from issuance of notes payable, net 7,000 7,000
Proceeds from issuance of convertible notes payable, net 8,394 5,507
Proceeds from warrant modification 2  
Repayment of notes payable   (255)
Repayment of convertible notes payable (500) (536)
Payment to related party (1,339)  
Net cash provided by financing activities 16,581 24,181
Effect of exchange rate changes on cash and cash equivalents 979 (5,537)
Net (decrease) increase in cash and cash equivalents (2,445) 2,141
Cash and cash equivalents, beginning of the period 3,040 2,175
Cash and cash equivalents, end of the period 595 4,316
Supplemental schedule of non-cash activities:    
Issuance of common stock for conversion of debt and accrued interest 20,760 18,743
Series C convertible preferred stock conversions 2,312 1,754
Capital expenditures included in accounts payable 73 88
Deemed dividend related to warrant modifications 662 825
Notes payable    
Supplemental disclosure of cash flow information    
Interest payments   (122)
Convertible notes payable    
Supplemental disclosure of cash flow information    
Interest payments $ (39) $ (103)